Category: Patent Litigation

    By Suresh Pillai — Beckman Asks for Dismissal in Patent Dispute with Sequenom Following the completion of a Markman hearing in a dispute with Sequenom Inc. concerning patents covering genotyping methods, Beckman Coulter has asked the District Court to dismiss its complaint.  In the lawsuit, Beckman Coulter had contended that Sequenom willfully infringed Beckman's…

    By Suresh Pillai — Caraco Motion for Summary Judgment in Prandin® Case Denied The U.S. District Court for the Eastern District of Michigan has denied a motion for summary judgment brought by Caraco Pharmaceutical Laboratories Ltd. and Sun Pharmaceutical Industries Ltd. (the majority shareholder of Caraco) in their patent suit with Novo Nordisk over…

    By Sherri Oslick — Assembled by Chief Judge Paul R. Michel (at right) of the United States Court of Appeals for the Federal Circuit, a committee comprising litigators and judges from across the nation has prepared and published model jury instructions for patent infringement cases based on the experience of those both on the…

    By Suresh Pillai — Settlement Announced in Oxycontin® Litigation KV Pharmaceutical Co. announced a settlement in its litigation with Purdue Pharma LP over the painkiller Oxycontin® (see "Court Report," June 11, 2007).  The settlement resolves three lawsuits filed by Purdue in the U.S. District Court for the Southern District of New York.  Purdue launched…

    By Suresh Pillai — Par Files Amended Complaint in Nascobal® Suit Par Pharmaceuticals filed an amended complaint against Fleming & Co. Pharmaceuticals, alleging patent and trademark infringement and unfair competition over Par's prescription nasal spray, Nascobal®.  The patent-in-suit, U.S. Patent No. 7,404,489, covers Par's spray-based vitamin B-12 product that was designed as an alternative…

    By Suresh Pillai — Bavarian Nordic Suit over TroVax® Survives Motion to Dismiss Last week, the U.S. District Court for the Southern District of California refused to dismiss an amended complaint filed by Bavarian Nordic A/S alleging that Oxford Biomedica infringes Bavarian Nordic's U.S. Patent Nos. 6,761,893, 6,913,752, 7,335,364, and 7,459,270 with respect to…

    By Kevin E. Noonan — The lawsuit filed by plaintiffs and represented by lawyers from the American Civil Liberties Union and the Public Patent Foundation (PUBPAT) is easy to decry in the biotechnology patent community.  Patent Docs will provide a detailed explication of the complaint, including a discussion of its many falsehoods, misstatements and…

    By Suresh Pillai — Novartis Denied Jury Trial in Famvir® Suit Last week, the U.S. District Court for the District of New Jersey denied Novartis Pharmaceutical Corp.'s request for a jury trial in its suit against Roxane Laboratories Inc.  In the lawsuit, filed in July 2008 (see "Court Report," May 18, 2008), Norvartis alleges…

    By Suresh Pillai — AstraZeneca Secures Temporary Restraining Order in PULMICORT® Case Last week, the U.S. District Court for the District of New Jersey barred Apotex from launching a generic version of PULMICORT® by granting AstraZeneca's requested temporary restraining order (see "Biotech/Pharma Docket," April 15, 2009).  The TRO will remain in effect at least…

    By Suresh Pillai — Resolution Announced in Johnson & Johnson Razadyne® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic…